Iradimed (IRMD) Capital Expenditures Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 10.17% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.81% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.35% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.08% |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn | -60.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.21% |
| Dec 31, 2025 | -223.69% |
| Sep 30, 2025 | 34.60% |
| Jun 30, 2025 | 140.89% |
| Mar 31, 2025 | 172.18% |
| Dec 31, 2024 | 185.04% |
| Sep 30, 2024 | 218.50% |
| Jun 30, 2024 | -12.23% |
| Mar 31, 2024 | 26.93% |
| Dec 31, 2023 | 38.36% |
| Sep 30, 2023 | 39.03% |
| Jun 30, 2023 | -261.51% |
| Mar 31, 2023 | 237.35% |
| Dec 31, 2022 | 67.61% |
| Sep 30, 2022 | 81.98% |
| Jun 30, 2022 | 19.96% |
| Mar 31, 2022 | 166.16% |
| Dec 31, 2021 | -4.89% |
| Sep 30, 2021 | 1.53% |
| Jun 30, 2021 | 158.75% |
| Mar 31, 2021 | 662.90% |
| Dec 31, 2020 | -30.22% |
| Sep 30, 2020 | 35.50% |
| Jun 30, 2020 | 145.06% |
| Mar 31, 2020 | 1,044.93% |
| Dec 31, 2019 | -32.71% |
| Sep 30, 2019 | 80.29% |
| Jun 30, 2019 | -26.72% |
| Mar 31, 2019 | -67.74% |
| Dec 31, 2018 | -33.89% |
| Sep 30, 2018 | 49.33% |
| Jun 30, 2018 | -57.46% |
| Mar 31, 2018 | -80.52% |
| Dec 31, 2017 | 111.02% |
| Sep 30, 2017 | -65.73% |
| Jun 30, 2017 | -12.06% |
| Mar 31, 2017 | -70.43% |
| Dec 31, 2016 | 77.21% |
| Sep 30, 2016 | -30.87% |